Hello all - we have some important news and encourage everyone to visit our website for additional information.
We announced that a recent independent review of our imaging data was positive and we are now setting a priority path to market for our MagSense imaging agent technology.
- Blinded review by expert panel of radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance Imaging (MRI).
- We are now prioritizing the development of our pipeline of tumour targeting MagSense® imaging agents for use with widely available commercial MRI systems as a faster path to patients and the market.
We will also be hosting a live webinar on 7 Feb @ 12pm AEDT to provide additional details and answer questions. We hope you join us!
Learn more: https://imagionbiosystems.com/news/priority-path-to-market-for-magsense-technology/
- Forums
- ASX - By Stock
- IBX
- Ann: Company Update - Phase 1 Study Independent Review
Ann: Company Update - Phase 1 Study Independent Review, page-2
-
- There are more pages in this discussion • 185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
IBX (ASX) Chart |
Day chart unavailable